Skip to main content

Advertisement

Log in

Adhesion molecules (ICAM-1 and VCAM-1) and diabetic retinopathy in type 2 diabetes

  • Original Paper
  • Published:
Journal of Molecular Histology Aims and scope Submit manuscript

Abstract

The expression of intercellular adhesion molecule (ICAM-1) and vascular cell adhesion molecule (VCAM-1) were studied in the conjunctiva of diabetic patients with and without retinopathy. All patients underwent a complete ophthalmic examination including ocular fundus and retinal fluorescein angiography. The indirect immunoperoxidase method was performed on 15 normal conjunctivas taken during cataract surgery (group 1), on 40 eyes of 40 patients with type 2 diabetes without diabetic retinopathy (DR) (group 2) and 13 eyes of 13 patients with DR (group 3). ICAM-1 and VCAM-1 are located in epithelial cells, vascular endothelial cells and in stromal cells. Our results show a statistically significant increase in the immunohistochemical expression of these proteins in the conjunctiva of diabetic patients with and without DR in comparison with normal conjunctiva (P = 0.001). Noteworthy, ICAM-1 and VCAM-1 are upregulated in the conjunctiva of diabetic patients with and without retinopathy, reflecting the inflammatory nature of this condition and suggesting a possible role for these mediators in the pathogenesis of diabetic microangiopathy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  • Abu-El-Asrar AM, Geboes K, Al-Kharashi S, Tabbara KF, Missotten L, Desmet V (1997) Adhesion molecules in vernal keratoconjunctivitis. Br J Ophthalmol 81:1099–1106

    Article  PubMed  CAS  Google Scholar 

  • Abu-El-Asrar AM, Dralands L, Missoten L, Al-Jadaan IA, Geboes K (2004) Expression of apoptosis markers in the retinas of human subjects with diabetes. Invest Ophthalmol Vis 45:2760–2766

    Article  Google Scholar 

  • Adamis AP (2002) Is diabetic retinopathy an inflammatory disease? Br J Ophthalmol 86:363–365

    Article  PubMed  CAS  Google Scholar 

  • Altannavch TS, Roubalova K, Kucera P, Andel M (2004) Effect of high glucose concentrations on expression of ELAM-1, VCAM-1 and ICAM-1 in HUVEC with and without cytokine activation. Physiol Res 53:77–82

    PubMed  CAS  Google Scholar 

  • Archer DB (1999) Diabetic retinopathy: some cellular, molecular and therapeutic considerations. Eye 13:497–523

    PubMed  Google Scholar 

  • Barile GR, Chang SS, Park LS, Reppucci VS, Schiff WM, Schmidt AM (1999) Soluble cellular adhesion molecules in proliferative vitreoretinopathy and proliferative diabetic retinopathy. Curr Eye Res 19:219–227

    Article  PubMed  CAS  Google Scholar 

  • Chakrabarti S, Cukiernik M, Hileeto D, Evans T, Chen S (2000) Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy. Diabetes Metab Res Rev 16:393–407

    Article  PubMed  CAS  Google Scholar 

  • Chen W, Jump DB, Grant MB, Esselman WJ, Busik JV (2003) Dyslipidemia, but not hyperglycemia, induces inflammatory adhesion molecules in human retinal vascular endothelial cells. Invest Ophthalmol Vis Sci 44:5016–5022

    Article  PubMed  Google Scholar 

  • Cheung AKH, Fung MKL, Lo ACY, Lam TTL, So KF, Chung SSM, Chung SK (2005) Aldose reductase deficiency prevents diabetes-induced blood-retinal barrier breakdown, apoptosis, and glial reactivation in the retina of db/db mice. Diabetes 54:3119–3125

    Article  PubMed  CAS  Google Scholar 

  • Ciulla TA, Harris A, Latkany P, Piper HC, Arend O, Garzozi H, Martin B (2002) Ocular perfusion abnormalities in diabetes. Acta Ophthalmol Scand 80:468–477

    Article  PubMed  Google Scholar 

  • Fong DS, Atello L, Gardner TW, King JL, Blankenship G, Cavallerano JD, Ferris FL, Klein R (2003) Diabetic retinopathy. Diabetes Care 26:226–229

    Article  PubMed  Google Scholar 

  • Joussen AM, Poulaki V, Mitsiades N, Kirchhof B, Koisumi K, Dohmen S, Adamis AP (2002a) Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-α suppression. FASEB J 16:438–440

    PubMed  CAS  Google Scholar 

  • Joussen AM, Poulaki V, Tsujikawa A, Qin W, Quam T, Xu Q, Moromizato Y, Bursell SE, Wiegand SJ, Rudge J, Loffe E, Yancopoulos GD, Adamis AP (2002b) Suppression of diabetic retinopathy with angiopoitin-1. Am J Pathol 160:1683–1693

    PubMed  CAS  Google Scholar 

  • Joussen AM, Poulaki V, Le ML (2004) A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J 10:1–17

    Google Scholar 

  • Kowluru RA, Odenbach S (2004) Role of interleukin-1beta in the pathogenesis of diabetic retinopathy. Br J Ophthalmol 88:1343–1347

    Article  PubMed  CAS  Google Scholar 

  • Kria L, Khalfaoui T, Mkannez G, Beltaief O, Anane R, Errais K, Tounsi L, Zhioua R, Jilani SB, Ouertani AM (2005) Immunohistochemical study of vascular endothelial growth factor (VEGF), tumor suppressor protein (p53) and intercellular adhesion molecule (ICAM-1) in the conjunctiva of diabetic patients. J Mol Histol 36:381–390

    Article  PubMed  CAS  Google Scholar 

  • Limb GA, Hickman-Casey J, Hollifield RD, Chignell AH (1999) Vascular adhesion molecules in vitreous from eyes with proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 40:2453–2457

    PubMed  CAS  Google Scholar 

  • Lloyd PA (1997) Clinical implications of vascular growth factors in proliferative retinopathies. Curr Opin Ophthalmol 8:19–31

    Article  Google Scholar 

  • Manaviat MR, Afkhami M, Shoja MR (2004) Retinopathy and microalbumineria in type II diabetic patients. BMC Ophthalmol 4:1471–1475

    Article  Google Scholar 

  • McLeod DS, Lefer DJ, Merges C, Lutty GA (1995) Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid. Am J Pathol 147:642–653

    PubMed  CAS  Google Scholar 

  • Meleth AD, Agron E, Chan CC, Reed GF, Arora K, Byrnes G, Csaky KG, Ferris FL, Chew EY (2005) Serum inflammatory markers in diabetic retinopathy. Invest Ophthalmol Vis Sci 46:4295–4301

    Article  PubMed  Google Scholar 

  • Platts KE, Benson MT, Rennie IG, Sharrard RM, Rees RC (1995) Cytokine modulation of adhesion molecule expression on human retinal pigment epithelial cells. Invest Ophtalmol Vis Sci 36:2262–2269

    CAS  Google Scholar 

  • Sampson MJ, Davies IR, Brown JC, Ivory K, Hughes DA (2002) Monocyte and neutrophil adhesion molecule expression during acute hyperglycemia and after antioxidant treatment type 2 diabetes and control patients. Arterioscler Thromb Vasc Biol 22:1187–1193

    Article  PubMed  CAS  Google Scholar 

  • Sangwan VS, Merchant A, De la Maza MS, Foster S (1998) Leucocyte adhesion molecule expression in scleritis. Arch Ophthalmol 116:1476–1480

    PubMed  CAS  Google Scholar 

  • Santos KG, Schneider JR, Souta KEP, Roisenberg I (2005) Prevalence of retinopathy in caucasian type II diabetic patients from the south of Brazil and relationship with clinical and metabolic factors. Braz J Med Biol Res 38:221–225

    PubMed  CAS  Google Scholar 

  • Stitt AW, Curtis TM (2005) Advanced glycation and retinal pathology during diabetes. Pharmacol Rep 57:156–168

    PubMed  Google Scholar 

  • Takahashi M, Ikeda U, Masuyama J, Funayama H, Kano S, Shimada K (1996) Nitric oxide attenuates adhesion molecule expression in human endothelial cells. Cytokine 8:817–821

    Article  PubMed  CAS  Google Scholar 

  • Tapp RJ, Shaw JE, Harper CA, De Courten MP, Blakau B, MacCarty DJ, Taylor HR, Welborn TA, Zimmet PZ (2003) The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care 26:1731–1737

    Article  PubMed  Google Scholar 

  • Varin R, Mulder P, Tamion F, Richard V, Henry JP, Lallemand F, Lerebours G, Thuillez C (2000) Improvement of endothelial function by chronic angiotensin-coverting enzyme inhibition in heart failure: role of nitric oxide, prostanoids, oxidant stress, and bradykinin. Circulation 102:351–356

    PubMed  CAS  Google Scholar 

  • Vorkauf M, Duncker G, Nolle B, Sterry W (1993) Adhesion molecules in normal human conjunctiva. An immunohistological study using monoclonal antibodies. Graefes Arch Clin Exp Ophthalmol 231:323–330

    Article  PubMed  CAS  Google Scholar 

  • Wilkinson-Berka JL (2004) Vasoactive factors and diabetic retinopathy: vascular endothelial growth factor, cycoloxygenase-2 and nitric oxide. Curr Pharm Des 10:3331–3348

    Article  PubMed  CAS  Google Scholar 

  • Yam JC, Kwok AKh (2007) Update on the treatment of diabetic retinopathy. Hong Kong Med J 13:46–60

    PubMed  Google Scholar 

Download references

Acknowledgements

The authors are indebted to Ms Linda Northrup for reviewing the English version of the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Taoufik Khalfaoui.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Khalfaoui, T., Lizard, G. & Ouertani-Meddeb, A. Adhesion molecules (ICAM-1 and VCAM-1) and diabetic retinopathy in type 2 diabetes. J Mol Hist 39, 243–249 (2008). https://doi.org/10.1007/s10735-007-9159-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10735-007-9159-5

Keywords

Navigation